You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

untreated ALL

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in United States (IO102/IO103, Nivolumab-Relatlimab)

Recruiting
  • Melanoma
  • Basking Ridge, New Jersey
  • +6 more
Jun 23, 2023

Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia Trial

Completed
Has Results
  • Acute Undifferentiated Leukemia
  • +13 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
Apr 5, 2022

Allergic Rhinitis, Allergic Rhinoconjunctivitis Trial in Vienna (nasal spray, no treatment)

Completed
  • Allergic Rhinitis
  • Allergic Rhinoconjunctivitis
  • nasal spray
  • no treatment
  • Vienna, Austria
    Ordination Dr. Petra Zieglmayer Vienna Challenge Chamber
Feb 19, 2021

Leukemia Trial (cyclophosphamide, cytarabine, daunorubicin HCl)

Active, not recruiting
Has Results
  • Leukemia
  • (no location specified)
Aug 16, 2021

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

Completed
  • Hemophilia
  • +7 more
    • Phoenix, Arizona
    • +26 more
    Jan 30, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Completed
    Has Results
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +23 more
    • Denver, Colorado
    • +2 more
    Jun 17, 2021

    Severe Hemophilia A Trial in Worldwide (Human cl rhFVIII)

    Completed
    Has Results
    • Severe Hemophilia A
    • Human cl rhFVIII
    • Sacramento, California
    • +36 more
    Dec 21, 2020

    PARP Inhibitor for Esophageal Squamous Cell Carcinoma Trial (Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only

    Not yet recruiting
    • PARP Inhibitor for Esophageal Squamous Cell Carcinoma
    • Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only non-small cell lung cancer arm) ,or Fluzoparib combined with capecitabine (only rectal cancer arm))
    • (no location specified)
    Sep 24, 2023

    Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)

    Not yet recruiting
    • Follicular Lymphoma
    • Tumor
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 30, 2023

    MDS Over Time - Comparison of Treated vs Untreated Patients

    Completed
    • Myelodysplastic Syndromes
      • Vienna, Austria
        Hanusch Krankenhaus, 3.Medizinische Abteilung
      Nov 21, 2022

      T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

      Recruiting
      • T Acute Lymphoblastic Leukemia
      • T Lymphoblastic Lymphoma
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 11, 2023

      Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • (no location specified)
      Jul 10, 2023

      Pompe Disease Trial in New York, Fairfax (biological, drug, other)

      Not yet recruiting
      • Pompe Disease
      • Cipaglucosidase alfa
      • +3 more
      • New York, New York
      • +1 more
      Nov 2, 2023

      Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

      Not yet recruiting
      • Uveal Melanoma
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Oct 5, 2023

      Obinutuzumab-based Therapy for Previously Untreated FL

      Recruiting
      • Follicular Lymphoma
      • Shanghai, Shanghai, China
        Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
      Jun 3, 2023

      Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Mitoxantrone hydrochloride liposome injection
      • +3 more
      • Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Jul 1, 2023

      Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Mitoxantrone hydrochloride liposome injection
      • +3 more
      • (no location specified)
      May 29, 2023

      Lymphoma, B-Cell Trial in San Antonio (R-Chop and Roflumilast)

      Not yet recruiting
      • Lymphoma, B-Cell
      • R-Chop and Roflumilast
      • San Antonio, Texas
        Mays Cancer Center, UT Health San Antonio
      Mar 31, 2023

      Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult, KRAS G12C Trial (JDQ443)

      Not yet recruiting
      • Non Small Cell Lung Cancer Metastatic
      • +2 more
      • (no location specified)
      Aug 11, 2023

      Relinking Diagnosed But Untreated HCV Patients Back Into Care.

      Recruiting
      • Hepatitis C Virus Infection
      • Contact the patient
      • Brussel, Belgium
        UZ Brussel
      Aug 1, 2023

      Hepatitis B, Chronic Trial in Worldwide (peginterferon alfa-2a [Pegasys])

      Completed
      Has Results
      • Hepatitis B, Chronic
      • peginterferon alfa-2a [Pegasys]
      • San Francisco, California
      • +38 more
      Oct 26, 2022

      Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic Trial in Scottsdale (Botensilimab, Balstilimab, Chloroquine

      Not yet recruiting
      • Pancreatic Cancer Metastatic
      • Pancreatic Adenocarcinoma Metastatic
      • Scottsdale, Arizona
        Clinical Trials Nurse Navigator
      Oct 3, 2023

      Irritable Bowel Syndrome Trial (Low FODMAP dietary regimen)

      Not yet recruiting
      • Irritable Bowel Syndrome
      • Low FODMAP dietary regimen
      • (no location specified)
      Jul 23, 2023

      Schizophrenia, First Episode Psychosis Trial in Glen Oaks, Queens (search engine advertisement campaign)

      Active, not recruiting
      • Schizophrenia
      • First Episode Psychosis
      • search engine advertisement campaign
      • Glen Oaks, New York
      • +1 more
      Sep 27, 2022

      Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1

      Not yet recruiting
      • Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
      • Ivosidenib 500mg
      • Placebo
      • (no location specified)
      Nov 7, 2023